CONTENTS:
- State medical marijuana laws and associated marijuana use, attitudes, and perceived social norms among adolescents in the U.S. Wong S.W., Buu A., Lin H.C., p. 383-392.
- A taxonomy of consumers' perspectives on the function of cannabis in their lives: A qualitative study in WA State, USA. Harwick R.M., Carlini B.H., Garrett S.B., p. 393-400.
- Sleep-Related Cannabis Expectancy Questionnaire (SR-CEQ): Initial development among college students. Goodhines P.A., LaRowe L.R., Gellis L.A., Ditre J.W., Park A., p. 401-411.
- A review of factors associated with age of first injection. McLaughlin M., Amaya A., Klevens M., O'Cleirigh C., Batchelder A., p. 412-420.
- Prescription stimulant use and associated risk factors for non-oral use among 10 to 18 year olds. Liu Y., Smith N.D.L., Lloyd S.L., Striley C.W., Cottler L.B., p. 421-432.
- Use of "poppers" among adults in the United States, 2015-2017. Le A., Yockey A., Palamar J.J., p. 433-439.
- An observational study of serum brain derived neurotrophic factor levels in patients with alcohol dependence during withdrawal. Kethawath S.M., Jain R., Dhawan A., Sarkar S., Kumar M., p. 440-446.
- A complex case of kratom dependence, depression, and chronic pain in opioid use disorder: Effects of buprenorphine in clinical management. Bowe A., Kerr P.L., p. 447-452.
- "Purple drank" (codeine and promethazine cough syrup): A systematic review of a social phenomenon with medical implications. Miuli A., Stigliano G., Lalli A., Coladonato M., D'Angelo L., Esposito F., et al., p. 453-462.
- Effect of ego depletion on interpersonal trust among individuals with substance use disorders. Liu C.J., Hao F., p. 463-471.
- Pilot evaluation of a residential drug addiction treatment combining traditional Amazonian medicine, ayahuasca and psychotherapy on depression and anxiety. Giovannetti C., Garcia Arce S., Rush B., Mendive F., p. 472-481.